Linked e-resources
Details
Table of Contents
Cytogenetics of Chronic Myeloid Leukemia (CML)
The Biology and Pathogenesis of Chronic Myeloid Leukaemia
Epidemiology of Chronic Myeloid Leukemia.-Imatinib and the first line CML Therapy
CML Therapy: A Focus on Second and Third Generation Tyrosine Kinase Inhibitors
Adverse events associated with ATP-competitive BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia
Pharmacoeconomic considerations for tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
Standardization of molecular monitoring for chronic myeloid leukemia: 2021 update
Prognostic Scores for Patients with Chronic Myeloid Leukemia under Particular Consideration of Disease-Specific Death
A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia
The Role of Hematopoietic Stem Cell Transplantation in CML
CML end-phase and blast crisis: implications and management
The Interferon-alpha Revival in CML
Managing Pregnancy in Chronic Myeloid Leukemia
Response-Related Predictors of Survival and of Treatment Free Remission in CML
Discontinuation or cessation of tyrosine kinase inhibitor treatment in Chronic myeloid leukemia patients with deep molecular response.
The Biology and Pathogenesis of Chronic Myeloid Leukaemia
Epidemiology of Chronic Myeloid Leukemia.-Imatinib and the first line CML Therapy
CML Therapy: A Focus on Second and Third Generation Tyrosine Kinase Inhibitors
Adverse events associated with ATP-competitive BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia
Pharmacoeconomic considerations for tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
Standardization of molecular monitoring for chronic myeloid leukemia: 2021 update
Prognostic Scores for Patients with Chronic Myeloid Leukemia under Particular Consideration of Disease-Specific Death
A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia
The Role of Hematopoietic Stem Cell Transplantation in CML
CML end-phase and blast crisis: implications and management
The Interferon-alpha Revival in CML
Managing Pregnancy in Chronic Myeloid Leukemia
Response-Related Predictors of Survival and of Treatment Free Remission in CML
Discontinuation or cessation of tyrosine kinase inhibitor treatment in Chronic myeloid leukemia patients with deep molecular response.